Disruption of sarcolemmal ATP-sensitive potassium channel activity impairs the cardiac response to systolic overload.
Disruption of sarcolemmal ATP-sensitive potassium channel activity impairs the cardiac response to systolic overload.
复制标题
DOI:
10.1161/circresaha.107.170795
复制
发表时间:
2008-10-24
影响因子:
20.1
通讯作者:
Chen Y
中科院分区:
文献类型:
--
作者:
Hu X;Xu X;Huang Y;Fassett J;Flagg TP;Zhang Y;Nichols CG;Bache RJ;Chen Y
Sarcolemmal ATP sensitive potassium Channels (KATP) act as metabolic sensors that facilitate adaptation of the left ventricle (LV) to changes in energy requirements. This study examined the mechanism by which KATP dysfunction impairs the LV response to stress using transgenic mouse strains with cardiac specific disruption of KATP activity (SUR1-tg mice) or Kir6.2 gene deficiency (Kir6.2 KO). Both SUR1-tg and Kir6.2 KO mice had normal LV mass and function under unstressed conditions. Following chronic transverse aortic constriction (TAC), both SUR1-tg and Kir6.2 KO mice developed more severe LV hypertrophy and dysfunction as compared with their corresponding wild type controls. Both SUR1-tg and Kir6.2 KO mice had significantly decreased expression of PGC-1α̣ and a group of energy metabolism related genes at both protein and mRNA levels̃. Furthermore, disruption of KATP repressed expression and promoter activity of PGC-1α in cultured rat neonatal cardiac myocytes in response to hypoxia, indicating that KATP activity is required to maintain PGC-1α expression under stress conditions. PGC1α gene deficiency also exacerbated chronic TAC-induced ventricular hypertrophy and dysfunction, suggesting that depletion of PGC1α can worsen systolic overload induced ventricular dysfunction. Both SUR1-tg and Kir6.2 KO mice had decreased FOXO1 after TAC, in agreement with the reports that a decrease of FOXO1 can repress PGC-1α expression. Furthermore, inhibition of KATP caused a decrease of FOXO1 associated with PGC-1α promoter. These data indicate that KATP channels facilitate the cardiac response to stress by regulating PGC-1α and its target genes, at least partially through the FOXO1 pathway.